Rationale and design of the IRON‐CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy

AIMS: Iron deficiency is common in heart failure with reduced ejection fraction (HFrEF). In patients with cardiac resynchronization therapy (CRT), it is associated with a diminished reverse remodelling response and poor functional improvement. The latter is partially related to a loss in contractile...

Descripción completa

Detalles Bibliográficos
Autores principales: Martens, Pieter, Dupont, Matthias, Dauw, Jeroen, Somers, Frauke, Herbots, Lieven, Timmermans, Philippe, Verwerft, Jan, Mullens, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Study Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989286/
https://www.ncbi.nlm.nih.gov/pubmed/31562751
http://dx.doi.org/10.1002/ehf2.12503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989286/
https://www.ncbi.nlm.nih.gov/pubmed/31562751
http://dx.doi.org/10.1002/ehf2.12503

Ejemplares similares